Tag: Biotechnology

Osivax
Europe, Global

Osivax Appoints Dr. Nicola Groth as Chief Medical Officer

LYON, France–(BUSINESS WIRE)–Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses and diseases, announced today the appointment of Dr. Nicola Groth, MD, PhD to its executive committee as Chief Medical Officer. She brings over 25 years of experience in vaccine development with considerable expertise in influenza vaccines, from early-stage clinical development to approval and post-marketing commitments. Dr. Groth joins … Continue reading Osivax Appoints Dr. Nicola Groth as Chief Medical Officer

Impact Newswire
Depixus
Europe, Global

Depixus Appoints Steve Klose as Chief Commercial Officer to Drive the Commercialization of Its Groundbreaking MAGNA™ Technology

PARIS–(BUSINESS WIRE)–Interactomics pioneer Depixus has appointed experienced life sciences sales leader, Steve Klose, to the newly created role of Chief Commercial Officer from January 16, 2024. Klose will lead the company’s commercial growth strategy to build a highly effective sales and support organization, strengthening its market presence ahead of the commercial launch of its first laboratory instrument, MAGNA One™, in 2024. “I’m thrilled to have … Continue reading Depixus Appoints Steve Klose as Chief Commercial Officer to Drive the Commercialization of Its Groundbreaking MAGNA™ Technology

Impact Newswire
Aiolos Bio
Global, United States

GSK Enters Agreement to Acquire Aiolos Bio

January 09, 2024 05:52 AM Eastern Standard Time SAN FRANCISCO & LONDON–(BUSINESS WIRE)–GSK plc (LSE/NYSE: GSK) and Aiolos Bio, Inc. (Aiolos) today announced that they have entered into an agreement under which GSK will acquire Aiolos, a clinical-stage biopharmaceutical company focused on addressing the unmet treatment needs of patients with certain respiratory and inflammatory conditions, for a $1 billion upfront payment and up to $400 … Continue reading GSK Enters Agreement to Acquire Aiolos Bio

Impact Newswire
Immunome, Inc.
Global, United States

Immunome Appoints Phil Roberts as Chief Technical Officer

January 04, 2024 08:00 AM Eastern Standard Time BOTHELL, Wash.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the appointment of Phil Roberts as Chief Technical Officer. Mr. Roberts has over three decades of experience in product development, global manufacturing, and commercialization of novel pharmaceutical products. “Working with Clay and the entire Immunome team to … Continue reading Immunome Appoints Phil Roberts as Chief Technical Officer

Impact Newswire
AdvanCell
Australia, Global

AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer

SYDNEY–(BUSINESS WIRE)–AdvanCell, a clinical-stage radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for patients with cancer, today announced the appointment of Anna Karmann, MD, PhD as the company’s Chief Medical Officer based in San Francisco. “Anna’s passion, insights, entrepreneurial mindset and expertise are invaluable to AdvanCell as we develop our portfolio of Targeted Alpha Therapies for patients globally.”Post this Dr. Karmann joins from RayzeBio, … Continue reading AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer

Impact Newswire
Mission Bio
Global, United States

Mission Bio Appoints Industry Veteran Brian Kim as CEO to Spearhead Single-Cell Genomic Solutions

Former Fortis Life Sciences CEO and private equity executive to drive expansion into clinical end markets and accelerate strategic biopharma collaborations SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Mission Bio, a leader in single-cell multiomic solutions for precision medicine, announced the appointment of Brian Kim as Chief Executive Officer. With over two decades of experience in the life sciences industry, he brings a unique combination of scientific innovation … Continue reading Mission Bio Appoints Industry Veteran Brian Kim as CEO to Spearhead Single-Cell Genomic Solutions

Impact Newswire
VERNAL BIOSCIENCES
Global, United States

Vernal Biosciences Announces Strategic Leadership Appointments to Drive Growth in mRNA and LNP Formulation

COLCHESTER, Vt.–(BUSINESS WIRE)–Vernal Biosciences, a leading manufacturing and services company specializing in mRNA and lipid nanoparticle (LNP) formulation, proudly announces the additions of Sven Lee, Chief Commercial Officer, and Richard P. Hamel, Chief Financial Officer to its leadership team. Both distinguished leaders will strengthen Vernal’s position as a premier mRNA and LNP Contract Development and Manufacturing Organization (CDMO) while using their deep experience to deliver … Continue reading Vernal Biosciences Announces Strategic Leadership Appointments to Drive Growth in mRNA and LNP Formulation

Impact Newswire
IEEE
Global, United States

Biomedical Technology Veteran Mike Hess Joins IEEE Pulse as Editor-in-Chief

PISCATAWAY, N.J.–(BUSINESS WIRE)–IEEE, the world’s largest technical professional organization dedicated to advancing technology for humanity, and the IEEE Engineering in Medicine and Biology Society (EMBS), today announced the appointment of biomedical technology veteran Mike Hess as editor-in-chief of IEEE Pulse. “The magazine should be a platform to inform and update the public about advances in the healthcare field, exchange ideas, and share knowledge and data. I … Continue reading Biomedical Technology Veteran Mike Hess Joins IEEE Pulse as Editor-in-Chief

Impact Newswire